Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Iridex (IRIX) EBT Margin (2016 - 2026)

Iridex has reported EBT Margin over the past 17 years, most recently at 5.66% for Q1 2026.

  • Quarterly results put EBT Margin at 5.66% for Q1 2026, down 6741.0% from a year ago — trailing twelve months through Jan 2026 was 9.59% (down 925.0% YoY), and the annual figure for FY2026 was 9.59%, down 925.0%.
  • EBT Margin for Q1 2026 was 5.66% at Iridex, up from 12.57% in the prior quarter.
  • Over the last five years, EBT Margin for IRIX hit a ceiling of 61.74% in Q4 2024 and a floor of 29.13% in Q1 2024.
  • Median EBT Margin over the past 5 years was 13.59% (2023), compared with a mean of 2.41%.
  • Biggest five-year swings in EBT Margin: surged 5992bps in 2022 and later plummeted -6741bps in 2026.
  • Iridex's EBT Margin stood at 42.18% in 2022, then increased by 29bps to 54.37% in 2023, then increased by 14bps to 61.74% in 2024, then crashed by -120bps to 12.57% in 2025, then surged by 55bps to 5.66% in 2026.
  • The last three reported values for EBT Margin were 5.66% (Q1 2026), 12.57% (Q3 2025), and 7.17% (Q2 2025) per Business Quant data.